Tag Archives: Summary of market research report

Global Canine Oral Chewable Tablets Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Canine Oral Chewable Tablets Market

Canine oral chewable tablets are the oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and fleas infections, and among others. Various additives and flavouring agents are used in the formulation of canine oral chewable tablets for masking the unpleasant taste and odour of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately.

Global Animal Feed Micronutrients Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Micronutrients are the nourishing components required by the life forms in less amounts to keep up the best possible physiological capacities. Creature encourage micronutrients are utilized as added substances alongside the regular sustain about under 100 mg for each day. The normally required creature bolster micronutrients incorporate iron, copper, zinc, magnesium, and others utilized for different creatures, for example, poultry, ruminants, equine, water, swine, and others. The creature sustain micronutrients are required to increment in execution and upgrading the propagation rate, development. Furthermore, micronutrients forestall, cure different illnesses and upgrade the absorbability in the creatures.
The global animal feed micronutrients market is growing at a significant CAGR due to increasing interest in owning pet animals. Increase in the consumption of dairy products in the food and beverage industry, growth in the population preferring for healthy meat and dairy products, rise in expenditure for the animal welfare and wellness, and focus on the development of fertility in animals expected to bolster the animal feed micronutrients market over the forecast period. In addition, increase in the prevalence of various diseases in animals, lack of nutrient food due to soil and water contamination, and increase in the awareness regarding adverse effects associated with the chemical food also fuel the animal feed micronutrients market over the forecast years. However, stringent regulatory policies for the nutritional products, lack of awareness regarding the animal feed micronutrients in untrained and poor farmers, who are preferring grass and other traditional food products in the rural area, and complexity in the dosing application might hamper the growth of animal feed micronutrients market over the forecast years.
A sample of this report is available upon request @
Global animal feed micronutrients market is segmented on the basis of product type, micronutrient type and livestock
Based on product type, animal feed micronutrients market is segmented into the following:
• Powders
• Liquids
Based on the micronutrient type, animal feed micronutrients market is segmented into the following:
• Copper
• Zinc
• Magnesium
• Calcium
• Iron
• Manganese
• Others
Based on the livestock, animal feed micronutrients market is segmented into the following:
• Poultry
• Ruminants
• Equine
• Aqua
• Swine
• Others
To view TOC of this report is available upon request @
Global animal feed micronutrients market is in the advanced stage as several local and international players are producing various animal feed micronutrients for improving the growth and health of the animals. Increase in the livestock expected to boost the animal feed micronutrients market.  Acquisitions & mergers, collaborations, joint ventures, and new product launch are the key strategies followed by various companies to increase their market share in global animal feed micronutrients market. For instance, in January 2016, Nutreco acquired the Micronutrients, Inc. for strengthening its micronutrients feed product portfolio. Similarly, in May 2016, Balchem Corporation and BASF collaborated for the development of novel micronutrient feed products in the swine industry for North America region. Moreover, diversification of business segments around the globe is also a key strategy to increase the company’s revenue in the animal feed micronutrients market. For instance, in March 2017, Archer Daniels Midland Company has expanded business plans in China to expand the company revenue.
Need more information about this report @
Geographically, animal feed micronutrients market is segmented into the following regions Viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia-Pacific holds the dominant share in animal feed micronutrients market followed by North America and Europe. Asia Pacific holds dominant share in animal feed micronutrients market owing to increase in the population preference on the healthy meat and dairy products majorly in India and China, increase in the adoption of pet animals, rapid urbanization, and rise in  cattle population. North America accounts for a key share of animal feed micronutrients market attributed to increase in the adoption of pet animals (according to American Pet Products Association, approximately 155 Mn canines and cats were owned in the U.S.), rise in expenditure for animal welfare and wellness, and increase in the awareness about the animal feed micronutrients expected to fuel the animal feed micronutrients market. Europe holds a significant share in animal feed micronutrients market due to increase in the preference for consumption of meat and dairy products, focus on fisheries in Europe countries such as Norway, Ireland, and U.K among others.
Some of the players in global animal feed micronutrients market are Archer Daniels Midland Company (U.S.), Lallemand Inc. (Canada), Cargill Inc. (U.S.), Kemin Industries Inc. (U.S.), Nutreco N.V. (Netherlands), Balchem Corporation (U.S.), Novus International Inc. (U.S.), Zinpro Corporation (U.S.), Alltech Inc. (U.S.), Aries Agro Ltd. (India), Agrium Advanced Technologies (Canada), Anco Animal Nutrition Competence GmbH (Austria), Zivo Bioscience, Inc. (U.S.), and NutriQuest (U.S.) to name a few.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

Sickle Cell Diseases Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Sickle Cell Diseases Treatment Market

Extreme decrease of aggregate RBC consider is called iron deficiency. It is likewise characterized as powerlessness of conveying the proper measures of oxygen by blood. Sickle cell illnesses are the sort of blood issue which are hereditarily acquired. Sickle-cell iron deficiency is the basic kind of SCD in which sickle molded cell is shaped. For the most part sickle cell sickness begins coming to fruition at early age i.e., inside a year after birth which prompts a few medical problems like assaults of agony which is additionally called as sickle-cell emergency, appendages swelling, bacterial contaminations and so on. Endless torment can be produced alongside the age. Sickle-cell ailments emerges when an individual acquired by anomalous duplicates of Hg quality from the each parent.

Latin America Over The Counter (OTC) Drugs Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Latin America Over The Counter Drugs Market

Over-the-counter (OTC) $@!#% Market, otherwise called the non-professionally prescribed medications that can be purchased without a solution. Over-the-counter medications are protected and powerful when the purchaser takes after the headings on the mark or as gave by a doctor. Over-the-counter (OTC) $@!#% are principally used to treat conditions that don’t require coordinate meeting of a specialist. Over-the-counter medications give moderate treatment and furthermore help to diminish the workload of doctors. Over-the-counter medications are effectively accessible in drug stores. Despite the fact that these items are considered as finished the-counter in light of the fact that these are not straightforwardly continued drug store counters and should be apportioned by a drug specialist in the wake of affirming age, character, and patient information in regards to use of the item.

Global Venous Thromboembolism Treatment Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Venous Thromboembolism Treatment Market
Venous thromboembolism is a malady caused by the coagulating of blood in the vein which prompts confinement of blood stream inside the circulatory framework. Venous thromboembolism is ordered into pneumonic embolism and profound vein thrombosis. Profound vein thrombosis is mostly happened because of the thickening of the blood in the profound vein (usually in the leg). The framed DVT cluster severs and streams to the lungs known as aspiratory embolism which is an extreme complexity of profound vein thrombosis (DVT). Venous thromboembolism normally happens in matured people with over 60 years. Individuals with overweight, people with thicker blood and the people experiencing immune system issue, for example, (lupus, rheumatoid joint pain and so on.) or malignancy are at higher danger of venous thromboembolism. Venous thromboembolism can cause unending confusions, for example, post-thrombotic disorder (PTS) or perpetual thromboembolic aspiratory hypertension (CTEPH). The manifestations related with the venous thromboembolism incorporate enlarged blood veins in legs and chest, oedema, fever, tachycardia, and dyspnoea. Lower limits are the most well-known site for DVT, however different areas influenced incorporate the mesenteric, furthest points, pelvic veins, and cerebral veins.
The venous thromboembolism treatment market is growing at a significant CAGR due to increase in geriatric population. Rise in the government expenditure, increase in the incidence of venous thromboembolism are fuelling the venous thromboembolism treatment market. Furthermore, increase in surgical procedures such as hip and knee replacements that are risk factors for venous thromboembolism conditions, growing patient awareness venous thromboembolism conditions expected to boost the venous thromboembolism treatment market growth over the forecast period.  However, high cost of deep vein thrombosis treatment, high unmet needs of currently available treatment procedures, and adverse effects associated with drugs hinder the growth of venous thromboembolism treatment market. Similarly, stringent regulatory approvals, the presence of alternatives treatments such as thrombectomy and percutaneous techniques are hindering the growth of venous thromboembolism treatment market over the forecast period.
A sample of this report is available upon request @
The venous thromboembolism treatment market is segmented on the basis of drug type, disease type, and distribution channel
Based on drug type, venous thromboembolism treatment market is segmented into the following:
• Factor Xa inhibitors
• Thrombolytic therapy
• Plasminogen activators
• Fondaparinux
• Dabigatran
• Warfarin
Based on disease type, the venous thromboembolism treatment market is segmented into the following:
• Deep vein thrombosis
• Pulmonary embolism
Based on distribution channel, the venous thromboembolism treatment market is segmented into the following:
• Hospital pharmacies
• Online Pharmacies
• Retail pharmacies
To view TOC of this report is available upon request @
The growth of venous thromboembolism treatment market is due to rise in prevalence of venous thromboembolism (According to the International Society on Thrombosis and Haemostasis, Inc.(ISTH), approximately 10 Mn cases of venous thromboembolism occur annually). The most commonly adopted strategies by industry players include new product launches with technological innovations, new product approvals, acquisitions & mergers, agreements, and collaborations to capture significant venous thromboembolism treatment market share. For instance, in March 2017, The Apex trial reported that extended use of betrixaban beyond the parenteral prophylaxis with enoxaparin reduces the venous thromboembolism incidence among the patients. Similarly, in May 2011, Eliquis (apixaban) approved In Europe for preventing venous thromboembolism after elective knee or hip replacement. Also, in January 2015, Bayer forms the collaboration with academic and governmental institutions for Rivaroxaban study in patients with a recent embolic stroke of undetermined source.
Geographically, venous thromboembolism treatment market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa. North America anticipated to hold the largest share in the venous thromboembolism treatment market owing to increase in the incidence (According to U.S. International Society on Thrombosis and Haemostasis, Inc. (ISTH) there are around 100,000 to 300,000 venous thromboembolism related deaths reported annually) and prevalence rate, rise in demand for advanced treatments, and increase in aging population in the North America region. Moreover, rise in healthcare expenditure, growing awareness regarding the disease and treatments, and increase in prevalence rate in the Europe region drives the venous thromboembolism treatment market over the forecast period. Asia-Pacific is a key region for venous thromboembolism treatment market due to increase in the government expenditure and healthcare infrastructure. However, high cost of the venous thromboembolism treatment, and low awareness regarding venous thromboembolism treatment among key stakeholders are the key factors hindering the venous thromboembolism treatment market growth in Latin America and Middle East and Africa regions.
Some of the players in venous thromboembolism treatment market are Sanofi (France), Pfizer Inc. (U.S.), Daiichi Sankyo Co. Ltd. (Japan) , Bristol Myers Squibb (U.S.), Johnson & Johnson Services, Inc. (U.S.), AbbVie Inc. (U.S.), Merck & Co. (U.S.), Astellas Pharma Inc. (Japan), Sawai Pharmaceuticals Co. Ltd. (U.S.), Abbott Laboratories (U.S.), Wockhardt Ltd (India), Bayer AG (Germany), and Dupont  (U.S.) to name a few.
Need more information about this report @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

Global Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Hepatitis C Virus Testing Market
Hepatitis C is a liver sickness which is transmitted by the contact with the blood of a contaminated individual. Hepatitis C indicate huge hereditary variety in populace around the world, because of high rate of viral RNA transformations. HCV has six variations (HCV genotypes 1, 2, 3, 4, 5, and 6), and 15 subtypes are recorded which differ in the rate of commonness around the world. Diverse sorts of gadgets are utilized for the determination of hepatitis C, including HCV viral load test, HCV neutralizer test, HCV genotype test and liver biopsy. Economical, fast, vigorous, and touchy logical gadgets are basic for viable, precise determination and observing of sickness treatment.
Increase in hepatitis C virus testing Market is mainly attributed to high incidence of chronic infection with hepatitis C virus. Furthermore, unhygienic blood donation practices are the considerable cause of spread of hepatitis C virus. Hepatitis C screening test is compulsory before the organ donation, increase in organ donation globally expected to boost the testing market growth. The increase in healthcare expenditure, changing lifestyle and increase in government initiatives are some of the key factors driving the growth of global hepatitis C virus antiviral Testing Market. In addition, growing healthcare awareness about the hepatitis C virus is also fueling the growth of global hepatitis C virus testing market. However, stringent regulation for approval of hepatitis C testing is the major factor expected to hamper the hepatitis C virus testing market.
A sample of this report is available upon request @
Globally, hepatitis C virus testing market is segmented based on technique, test type, end-user.
Based on technique, hepatitis C virus testing market is segmented as:
• Polymerase Chain Reaction Tests
• Immunoassays
• Others
Based on test, hepatitis C virus testing market is segmented as:
• Hepatitis C antibody
• Hepatitis C RNA quantitative test
• Hepatitis C RNA qualitative test
• Hepatitis C RIBA
• Hepatitis C genotype
• Viral load
Based on the end-user, hepatitis C virus testing market is segmented as:
• Hospitals
• Diagnostic Centres
• Blood Donation centers
To view TOC of this report is available upon request @
When compared to hepatitis A and hepatitis B Prevalence of hepatitis C is low. According to Institute of Liver and Biliary Sciences India (ILBS) around 3% of population globally, infected with hepatitis C virus, therefore minimum R&D investments by market players to develop new and effective hepatitis C virus tests. Among the all tests, HCV antibody testing is expected to occupy more share because antibody testing is the primarily used test for HCV testing. In end user segment, diagnostic centers is expected to have major market share in HCV testing market. Application of new electrochemical immune sensor and genosensor technologies in HPV testing are expected to change conventional HPV testing practices.
Need more information about this report @
Geographically, hepatitis C virus testing Market is divided into Asia-Pacific, Latin America, North America, Europe and The Middle East and Africa. Europe hepatitis C market is expected to grow at significant rates owing to incidence of hepatitis C virus diseases. According to WHO European region have 1.5% and Eastern Mediterranean has 2.3% prevalence of HCV diseases that shows significant variations in genes in population globally due to high rates of mutation of viral RNA. Asia Pacific is expected to be having lucrative market growth over the forecasting period owing to disease prevalence rates.
Some of the players in global hepatitis C virus testing Market include Abbott Laboratories (U.S.), Bio Rad Laboratories Inc. (U.S.), Qiagen (Germany), Bayer AG (Switzerland), OraSure Technologies (U.S.), Siemens Healthcare GmbH (Germany), BioGenex (U.S.), H. Hoffman-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostic Inc. (U.S.), among others.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

Global Hepatitis C Treatment Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Hepatitis C is an irresistible infection caused by Hepatitis C infection (HCV) and influences essentially the liver. Hepatitis C is normally caused by blood to blood contacts, for example, intravenous medication utilize, unsterilized hardware, blood transfusions, and ***. Hepatitis C may likewise cause from mother to embryo amid birth. Individuals with liquor abuse and HIV disease of all ages assemble are at expanded hazard. As of now, there is no immunization accessible to treat hepatitis C conditions. In any case, different medications, for example, protease inhibitors, HCV polymerase inhibitors, and HCV NS5A inhibitors are normally used to treat Hepatitis C. Beginning time of contamination regularly has no side effects. The basic phase of contamination may show indications, for example, fever, dull pee, stomach agony, and yellow-tinged skin event. The seriousness in hepatitis C may prompt liver cirrhosis, liver disease, liver disappointment, and now and again likewise causes the widened veins in the throat and stomach. Hepatitis C can be averted by utilizing disinfected hardware, screening of blood givers, keeping away from numerous sexual accomplices, and abstaining from sharing of infusions and razors.
The global market for Hepatitis C treatment market is expected to grow at a significant CAGR due to increase in the prevalence of Hepatitis C infection. Rising awareness regarding Hepatitis C treatment, increase in healthcare expenditure, and government initiatives and various NGO’s creating awareness regarding the Hepatitis C treatment is expected to fuel the market growth over the forecast period. In addition, rise in the funding in research and development activities for Hepatitis C treatment and strong pipeline products might boost the global Hepatitis C treatment market over the forecast period. However, lack of antibiotics in the market, high cost of medications, and lack of hepatitis C infection awareness in poor countries might hamper the growth of global Hepatitis C treatment market over the forecast period.
A sample of this report is available upon request @
Hepatitis C treatment market segmented on the basis of drug class, route of administration, and distribution channel
Based on drug class, the hepatitis C treatment market has been segmented into the following:
• Polymerase Inhibitors
• NS5A Inhibitors
• Interferons
• HCV protease inhibitors
• Combination Therapy
Based on route of administration, the hepatitis C treatment market has been segmented into the following:
• Oral
• Parenteral
Based on distribution channel, the hepatitis C treatment market has been segmented into the following:
• Retail Pharmacies
• Hospital Pharmacies
• Others
To view TOC of this report is available upon request @
Increase in prevalence of hepatitis C infection and liver cirrhosis expected to fuel the growth of Hepatitis C treatment market. According to the World Health Organization (WHO), globally there are 80 Mn people suffers from chronic hepatitis C virus, in that approximately 700,000 will die each year as a result of the infection. Acquisitions and mergers, collaborations, launching of new products, increase in research and development activities, and approvals for new products from various drug regulatory bodies such as U.S. Food and Drug Administration are some strategies followed by various companies to increase their market share in global hepatitis C treatment market. For instance, in July 2011, Merck MSD, inked an agreement with Roche for the marketing approvals of Victreli (Boceprevir) triple combination therapy with peginterferon alfa and ribavirin (peg/riba). In addition, in August 2011, Vertex Pharmaceuticals Incorporated announced that Health Canada approved its Incivektm (Telaprevir) tablets for people with genotype 1 chronic hepatitis C with compensated liver disease. In January 2014, European Commission (EC) granted marketing authorization for Gilead’s Sovaldi (Sofosbuvir) to treat chronic hepatitis C infection.
Need more information about this report @
Geographically, the hepatitis C treatment market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global hepatitis C treatment market followed by Europe and Asia-Pacific. Increase in prevalence of hepatitis C infection (according to Centres for Disease Prevention and Control (CDC), approximately 2.7-3.9 Mn people in the United States are chronically infected with hepatitis C Virus), rise in the awareness among the key stakeholders towards the use of novel products and technologies to treat the hepatitis C, and increase in research and development activities are the key factors bolster the hepatitis C treatment market in North America region. Europe holds a key share in hepatitis C treatment market owing to increase in prevalence of Hepatitis C infection (according to European centre for Disease Prevention and Control approximately 5.9 Mn people are suffering from HCV infection), rise in the geriatric population, change in the lifestyle, people involving in the unprotected sexual intercourse, and increase in the research and development activities might boost the hepatitis C treatment market in Europe region. Asia-Pacific hepatitis C treatment market growth is attributed to increase in the prevalence of hepatitis C infection, rise in the population in Asia-Pacific region, and increase in the healthcare infrastructure. The Middle East & Africa region has high prevalence of HCV infection majorly in Egypt that is approximately 8434 prevalent cases per 100,000 people.
Some of the players in Hepatitis C treatment market are GlaxoSmithKline, plc. (U.K.), Bristol-Myers Squibb (U.S), F. Hoffmann- La Roche Ltd. (Switzerland), Merck & Co, Inc. (U.S),  Johnson & Johnson Services, Inc. (U.S.), Gilead Sciences (U.S.), AbbVie Inc. (U.S.), Vertex Pharmaceuticals Inc. (U.S.), and Kadmon Holdings, Inc. (U.S.) to name a few.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
I

Global Hepatitis B Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Hepatitis B Virus Testing Market
Hepatitis B is a liver sickness caused by the Hepatitis B infection (HBV). Hepatitis B viral contamination extents can shape mellow disease which most recent couple of weeks and an unending contamination that may prompt liver issue and even demise. Hepatitis B is one of the worldwide medical issue. Hepatitis B can cause incessant disease and puts individuals at high danger of death from cirrhosis and liver tumor. The infection is transmitted through contact with the blood or other body liquids of a tainted individual. As per World Health Organization, 257 Mn individuals are living with hepatitis B infection disease worldwide and in 2015, 887 000 hepatitis B came about passings.
Increase in liver cancer cases, growing aging population, healthcare spending and urbanization. Leading to better monitoring and screening procedures. In addition, government initiatives in growing awareness in public, increase in R&D spending by companies and growing demand for bio marker tests due to its accuracy expected to boost the hepatitis B virus testing market during the forecast period. However, factors such as lack of awareness in developing countries, stringent regulatory rules, rigid competition and high cost of testing are expected to hamper the hepatitis B virus testing market over the forecast period.
A sample of this report is available upon request @
The global hepatitis B testing market is classified on the basis of test type, technique end use, and geography.
Based on test type, the global hepatitis B diagnostic test market is segmented into the following:
• Hepatitis B surface antigen test (HBsAg)
• Anti-hepatitis B surface antibody test
• Hepatitis B core antigen test (HBcAb)
• Anti-hepatitis B core antibody test
• HBV DNA test
• Others
Based on techniques, the global hepatitis B diagnostic test market is segmented into the following:
• PCR
• Radioimmunoassay (RIA)
• Enzyme-linked immunosorbent assay (ELISA)
• Others
Based on end-user type, the global hepatitis B diagnostic test market is segmented into the following:
• Hospitals
• Diagnostic centers
• Clinics
To view TOC of this report is available upon request @
Currently, more than 13 immunoassays are available to diagnose hepatitis B virus at an early stage. They can also be used to distinguish acute and chronic hepatitis B infections. Many governments in the European countries and the US made it mandatory for the people to go through the screening and proper monitoring since hepatitis B takes the time to develop and is not easily recognizable. There are some curative therapies available but they are not very efficient. It is expected that many innovative therapies which have shown positive results in trials will occupy the market in the coming years. Many companies have products related to hepatitis B in their pipeline. Vendors are developing devices and systems that help integrate laboratory applications. For instance, in 2010 the COBAS 6000 modular platform by Roche Diagnostics offers optimum efficiency and consolidation in medium- and high-volume laboratories.
Need more information about this report @
Geographically, hepatitis B testing market has been segmented into North America, Europe, Latin America, Asia-Pacific, and The Middle East & Africa. North America dominated the hepatitis B therapeutics market owing to the high awareness levels, availability of improved infrastructure, and favourable government initiatives relating to the promotion of hepatitis B therapeutics. Europe is the second largest market for hepatitis B therapeutics driven by rising geriatric population, high rates of chronic infections in Central and Eastern Europe e European Centre for Disease Prevention and Control (ECDC) estimates an overall hepatitis B incidence of 1.49 per 100 000, prevalence of hepatitis B is the highest in Middle East & Africa where adult population is chronically infected. According to World Health Organization (WHO), 2% to 5% of population is affected with hepatitis B virus in Asia Pacific region. And most people die with liver diseases.
Some of the players hepatitis B testing market are Onsite Lab Holding AG (MedMira Inc.) (Switzerland), F. Hoffmann-La Roche (Switzerland), Abbott Laboratories (USA), Siemens AG (Siemens Healthcare GmbH) (Germany), Fisher Bioblock Bolding (Thermo Fisher Scientific) (France), Innovita biological technology Co. Ltd. (China), General Biologicals Corporation (Taiwan), Nantong Diagnos Biotechnology Co. Ltd. (China), Blue Cross Bio-Medical (China) Co. Ltd., BioGenex (U.S.), and Abnova Corporation (U.S.), among others.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
I

Global Heart Valves Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Global Heart Valves Market

Heart valves are the medicinal gadgets which are utilized as a part of the substitution of flawed heart valve. Heart valves are significantly 2 sorts, they are organic or tissue and mechanical heart valves. Natural heart valves are comprised of different tissues, for example, porcine, cow-like and human tissues. Heart valves produced using human tissues are known as homografts or allografts. The significant preferred standpoint of tissue valves over mechanical valve is mechanical heart valves can cause draining and increment the odds of reoperations in geriatric individuals. Since the utilization of tissue heart valves in individuals of this age amass brings down the dangers of dying. Doctors are progressively settling on this technique as it ready to lessen the utilization of oral anticoagulation $@!#% for the administration of draining intricacies.

Designed by CyFocus.com
Powered by CyFocus.net